Practicability of Serum Kallistatin Levels as a Biomarker in the Diagnosis of Tubo-Ovarian Abscess.

Autor: Birsen MB; Department of Obstetrics and Gynecology, Antalya Training and Research Hospital, Antalya, Turkey., Erturk D; Department of Obstetrics and Gynecology, Antalya Training and Research Hospital, Antalya, Turkey., Onder D; Department of Obstetrics and Gynecology, Antalya Training and Research Hospital, Antalya, Turkey., Eryilmaz AI; Department of Obstetrics and Gynecology, Aksaray Training and Research Hospital, Antalya, Turkey., Kaba M; Department of Obstetrics and Gynecology, Antalya Training and Research Hospital, Antalya, Turkey., Ellidag HY; Department of Biochemistry, Antalya Training and Research Hospital, Antalya, Turkey., Inal HA; Department of Obstetrics and Gynecology, Antalya Training and Research Hospital, Antalya, Turkey.

Publikováno v: Surgical infections [Surg Infect (Larchmt)] 2024 Nov; Vol. 25 (9), pp. 668-673. Date of Electronic Publication: 2024 Aug 13.

An evaluation of serum blood parameters and amyloid-A levels in women with hyperemesis gravidarum; A prospective observational study.

Autor: Onder D; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Birsen MB; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Erturk D; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Eryilmaz AI; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Ozdemir O; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Aykal G; Antalya Training and Research Hospital, Department of Obstetrics and Gynecology, Antalya, Turkey., Ozturk Inal Z; Konya City Hospital, Department of Obstetrics and Gynecology, Konya, Turkey.

Publikováno v: Medicine [Medicine (Baltimore)] 2024 Sep 20; Vol. 103 (38), pp. e39695.

Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.

Autor: Faber J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Berger M; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics, and Epidemiology, Bonn, Germany., Wilke C; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Hubener-Schmid J; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Schaprian T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Santana MM; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal., Grobe-Einsler M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Onder D; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Koyak B; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK., Garcia-Moreno H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK., Gonzalez-Robles C; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK., Lima M; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal., Raposo M; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.; Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal., Melo ARV; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal., de Almeida LP; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal., Silva P; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Pinto MM; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., van de Warrenburg BP; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands., van Gaalen J; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands., de Vries J; University Medical Center Groningen, Neurology, Groningen, the Netherlands., Oz G; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Joers JM; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Synofzik M; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Tübingen, Germany., Schols L; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Tübingen, Germany., Riess O; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Infante J; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Centro de investigación biomédica en red de enfermedades neurodegenerativas (CIBERNED), Universidad de Cantabria, Santander, Spain., Manrique L; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain., Timmann D; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany., Thieme A; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany., Jacobi H; Department of Neurology, University Hospital of Heidelberg, Heidelberg, Germany., Reetz K; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, Aachen, Germany., Dogan I; Department of Neurology, RWTH Aachen University, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, Aachen, Germany., Onyike C; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Povazan M; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Schmahmann J; Ataxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Ratai EM; Massachusetts General Hospital, Department of Radiology, A. A. Martinos Center for Biomedical Imaging and Harvard Medical School, Charlestown, MA, USA., Schmid M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics, and Epidemiology, Bonn, Germany., Klockgether T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany.

Publikováno v: Annals of neurology [Ann Neurol] 2024 Feb; Vol. 95 (2), pp. 400-406. Date of Electronic Publication: 2023 Dec 05.

Stage-dependent biomarker changes in spinocerebellar ataxia type 3.

Autor: Faber J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Berger M; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology., Carlo W; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Hübener-Schmid J; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Schaprian T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Santana MM; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal., Grobe-Einsler M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Onder D; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Koyak B; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany., Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK., Garcia-Moreno H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK., Gonzalez-Robles C; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK., Lima M; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal., Raposo M; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.; Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal., Melo ARV; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal., de Almeida LP; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal., Silva P; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal., Pinto MM; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal., van de Warrenburg BP; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center., van Gaalen J; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center.; Department of Neurology, Rinjstate Hospital, Arnhem, The Netherlands., de Vries J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany.; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology.; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.; Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal.; Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center.; Department of Neurology, Rinjstate Hospital, Arnhem, The Netherlands.; University Medical Center Groningen, Neurology.; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Centro de investigación biomédica en red de enfermedades neurodegenerativas (CIBERNED), Universidad de Cantabria, Santander, Spain.; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen.; Department of Neurology, University Hospital of Heidelberg, Germany.; Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074 Aachen, Germany.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland USA.; Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Ataxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School.; Massachusetts General Hospital, Department of Radiology, A. A. Martinos Center for Biomedical Imaging and Harvard Medical School, Charlestown, Massachusetts, USA., Jeroen; University Medical Center Groningen, Neurology., Oz G; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Joers JM; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Synofzik M; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Schöls L; Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Riess O; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Infante J; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Centro de investigación biomédica en red de enfermedades neurodegenerativas (CIBERNED), Universidad de Cantabria, Santander, Spain., Manrique L; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain., Timmann D; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen., Thieme A; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen., Jacobi H; Department of Neurology, University Hospital of Heidelberg, Germany., Reetz K; Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074 Aachen, Germany., Dogan I; Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074 Aachen, Germany., Onyike C; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland USA., Povazan M; Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA., Schmahmann J; Ataxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School., Ratai EM; Massachusetts General Hospital, Department of Radiology, A. A. Martinos Center for Biomedical Imaging and Harvard Medical School, Charlestown, Massachusetts, USA., Schmid M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology., Klockgether T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Neurology, University Hospital Bonn, Bonn, Germany.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Apr 25. Date of Electronic Publication: 2023 Apr 25.

Prognostic Significance of Tumor–Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Autor: Girolami, Ilaria¹ (AUTHOR) ilaria.girolami@sabes.it, Damiani, Domenico¹ (AUTHOR), Negro, Rosa¹ (AUTHOR), Abousiam, Monir² (AUTHOR), Gazzini, Luca² (AUTHOR), Calabrese, Luca² (AUTHOR), Hanspeter, Esther¹ (AUTHOR)

Publikováno v: Cells (2073-4409). Nov2024, Vol. 13 Issue 21, p1772. 12p.